Go to homepage
Our executive team
Henry Kauftheil
Chairman, CEO & Co-Founder
Josh Rothenberg
President & Co-Founder
Stuart Paul
Chief Operating Officer
Yoni Novak
Chief Financial Officer
Kim Hernandez Kuch
Chief Marketing Officer
Dr. Allen Kaufman
Chief Medical Officer
Alice Hellebrand
Chief Nursing Officer
Mayer Kotlarsky
Chief Development Officer & SVP, Operations
Jonathan Paull
Chief Compliance Officer & General Counsel
Robert Aberman
Senior Vice President, Population Health
Peg Brubaker
Chief Human Resources Officer
Yehuda Markovits
Chief Legal Officer & Corporate Counsel
Solomon Rubinfeld
SVP, Strategic Operations & Chief Procurement Officer
Dr. Nathan Levin
Chairman of Medical Advisory Board & Director of Research
Jordan Ledvina
Chief Information Officer
Our advisors

Combined, our board has over 200 years of healthcare, technology, and business experience.

Jerry Levin
Former CEO at Time Warner and HBO; Executive Chairman at Startup Health
”Dialyze Direct has completely changed the future of kidney disease and the lives of those who battle it . . . including me.”
Robert Ehrlich
Former CEO/Chairman/Director at Fresenius (CEO/Chairman 1987-1989, Director 1987-1996), Former CFO/Director at Mattel (CFO 1972-1973, Director 1973 -1987)
“Having led an international dialysis company, I am cognizant of the unique challenges of providing care across a large landscape. Dialyze Direct has proven that their uniquely compassionate approach can deliver superior outcomes across the nation. This is an important step forward for kidney care.”
Ilan Kaufthal
Chairman at Israel Discount Bank of NY; Former Chairman at Eastwind Advisors; Former Vice Chairman at Bear Stearns & Co
“I am delighted to be a part of Dialyze Direct and to contribute what I can in helping them bring their unique care model to countless more suffering with kidney disease across the country. With their unprecedented outcomes and dynamic vision, we can heal the fractured system of renal care​.”
Dick Cashin
President, Founder at One Equity Partners; Former President at Citigroup Venture Capital
“Dialyze Direct developed a protocol for the difficult geriatric ESRD patient group, improving patient outcomes and both payer and SNF economics. The company is increasing patient census rapidly across over 100 SNFs in 8 key states, and is building a profitable, essential business with an enormous market.”
Linda Donald
Former President of North Business Unit at Fresenius Medical Care
“Dialyze Direct’s use of recent developments in dialysis technology combined with more frequent treatments provides an unparalleled level of dialytic efficiency. Dialyze Direct enhances patient convenience substantially in eliminating the arduous, expensive travel to and from the dialysis center, largely paid for by the government. The company's unique approach is effectively addressing previously unexamined and neglected difficulties.”
Dr. Nathan Levin
Founder at Renal Research Institute; President at Michigan End-Stage Renal Disease (ESRD) Network; Former President at Renal Physicians Association (RPA); President at RPA Research and Education Foundation
“As an individual who has been involved in dialysis for over six decades, it has been extremely fulfilling to participate in the special opportunity of applying this life-saving technology to the elderly, the sickest and most vulnerable patients.”
Dr. Benjamin Tandowski
Former CTO at Ness and Former President at Ness USA
“The United States is facing unprecedented challenges in the provision of proper kidney care with the ever-growing number of patients and costs. The underlying obstacles have remained unaddressed for too long. Dialyze Direct is pioneering improved treatment methodologies and technologies for countless patients across the country. This shift in outcomes benefits the broader institutions involved, paving a path towards a positive future for all stakeholders.”
Paul Hellman
CEO of Caretech Supplies
"It’s a very rare alignment of stakeholder interests across the spectrum. Patients, nursing homes and payers all stand to benefit substantially from the value proposition of Dialyze Direct’s model of care."
Michael Cooper
Former CEO at Metro Medical; Principal at Bell Curve Innovations
"As a provider with over 30 years of experience in nephrology, I’m excited to join in providing access to value-based care solutions to vulnerable patients across the ever-increasing footprint of Dialyze Direct. The patient should always come first and I’m happy to actualize that with Dialyze Direct’s unique care model and unprecedented outcomes."